WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 48'5901 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 44'1681 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 8'495  8'464  8'433  8'402  8'372  8'020  7'670  7'555 
Births 81  80  79  79  78  80  90  89 
Surviving infants 81  80  79  78  78  80  89  87 
Pop. less than 5 years 407  402  397  395  394  419  442  423 
Pop. less than 15 years 1'231  1'230  1'233  1'239  1'253  1'367  1'337  1'538 
Female 15-49 years 2'002  2'018  2'032  2'043  2'050  1'991  1'962  1'819 

Number of reported case

(Click for retrospective incidence data for Austria)
Diphtheria
Japanese encephalitis
Measles 36  68  52  49 
Mumps
Pertussis 571  309  414  183  117  234  186 
Polio*
Rubella 23  252 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Austria)
Vaccine year result method % card seen                                                
BCG         
DTP1          61  75 
DTP3          83  81  90 
HepB_BD          65 
HepB3          83  33 
Hib3          83  72 
JapEnc         
MCV          76  75  60 
MCV2          64  35 
PCV1         
PCV3         
Pol3          83  71  90 
Rota1         
Rota_last          61 
Rubella1          76 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Austria)
BCG 90 
DTP1 93  93  93  93  93  99  96  96 
DTP3 83  83  83  83  83  81  90  90 
HepB3 83  83  83  83  83  33 
HepB_BD
Hib3 83  83  83  83  83  72 
MCV 76  76  76  76  76  75  60 
MCV2 64  64  64  64  64  35 
PCV3
Pol3 83  83  83  83  83  71  90  90 
Rota_last 61  61  61  61  61 

Number of districts in the country 121  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 0-1 year (x3); 1-2 years; Yes
HPV 9 years; (x3) Yes private sector
HepB 12-13 years; Yes school-booster
MMR 1-2 years (x2); Yes second dose earliest 28 days after first dose; catch-up vaccination at any age
Pneumo_conj 0-1 year (x3); 1-2 years; Yes children belonging to defined high risk groups
Rotavirus 7 weeks - 6 months (x2 or 3); Yes 3rd dose depending on vaccine

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR         Yes  Yes  Yes 
What years does the MYP cover? number         1998 - ongoing  1998 - ongoing  1998 - ongoing 
Nº of districts with microplans that include activities to raise immunization coverage number              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR              

System performance

Total Nº districts in country number   121  121  121  121  121  121 
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%  
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND              
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR         Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%         83  83  88 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.